{"disease":{"id":"stage-iva-thymoma","name":"stage iva thymoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03295227","title":"Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}